McKesson Corporation (MCK) - Total Liabilities
Based on the latest financial reports, McKesson Corporation (MCK) has total liabilities worth $92.19 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of McKesson Corporation's assets are long-term investments to see how much of total assets are deployed in long-term investments.
McKesson Corporation - Total Liabilities Trend (1995–2026)
This chart illustrates how McKesson Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see McKesson Corporation total assets.
McKesson Corporation Competitors by Total Liabilities
The table below lists competitors of McKesson Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pinduoduo Inc
F:9PDA
|
Germany | €214.28 Billion |
|
Cambricon Technologies Corp Ltd
SHG:688256
|
China | CN¥4.64 Billion |
|
Agnico Eagle Mines Limited
TO:AEM
|
Canada | CA$9.18 Billion |
|
UBS Group AG
SW:UBSG
|
Switzerland | CHF1.53 Trillion |
|
GSK PLC SP. ADR/2 NEW
F:GS70
|
Germany | €44.56 Billion |
|
China Yangtze Power Co Ltd
SHG:600900
|
China | CN¥322.17 Billion |
|
Air Liquide SA
PA:AI
|
France | €24.97 Billion |
|
CVS Health Corp
NYSE:CVS
|
USA | $185.68 Billion |
Liability Composition Analysis (1995–2026)
This chart breaks down McKesson Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See McKesson Corporation net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -21.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how McKesson Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for McKesson Corporation (1995–2026)
The table below shows the annual total liabilities of McKesson Corporation from 1995 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $83.16 Billion | +8.23% |
| 2025-03-31 | $76.83 Billion | +11.29% |
| 2024-03-31 | $69.04 Billion | +8.20% |
| 2023-03-31 | $63.81 Billion | -1.97% |
| 2022-03-31 | $65.09 Billion | +2.39% |
| 2021-03-31 | $63.57 Billion | +16.56% |
| 2020-03-31 | $54.54 Billion | +9.09% |
| 2019-03-31 | $49.99 Billion | +2.31% |
| 2018-03-31 | $48.87 Billion | +1.03% |
| 2017-03-31 | $48.37 Billion | +4.81% |
| 2016-03-31 | $46.15 Billion | +3.94% |
| 2015-03-31 | $44.40 Billion | +7.14% |
| 2014-03-31 | $41.44 Billion | +49.52% |
| 2013-03-31 | $27.72 Billion | +5.54% |
| 2012-03-31 | $26.26 Billion | +10.97% |
| 2011-03-31 | $23.67 Billion | +14.57% |
| 2010-03-31 | $20.66 Billion | +8.30% |
| 2009-03-31 | $19.07 Billion | +3.20% |
| 2008-03-31 | $18.48 Billion | +4.60% |
| 2007-03-31 | $17.67 Billion | +17.27% |
| 2006-03-31 | $15.07 Billion | +11.62% |
| 2005-03-31 | $13.50 Billion | +21.90% |
| 2004-03-31 | $11.07 Billion | +15.02% |
| 2003-03-31 | $9.63 Billion | +4.80% |
| 2002-03-31 | $9.19 Billion | +17.17% |
| 2001-03-31 | $7.84 Billion | +18.60% |
| 2000-03-31 | $6.61 Billion | +10.11% |
| 1999-03-31 | $6.00 Billion | +49.91% |
| 1998-03-31 | $4.01 Billion | +7.75% |
| 1997-03-31 | $3.72 Billion | +56.05% |
| 1996-03-31 | $2.38 Billion | -0.99% |
| 1995-03-31 | $2.41 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more